Zen Brief

Drug regulators, election campaigns and web security are in focus today. Two health stories touch on how the FDA reviews new treatments, while two political stories raise questions of discipline ahead of the midterms.

1. 1 Repurposed drugs test could reshape Alzheimer's FDA approval pathA federally funded trial tests existing diabetes and ADHD drugs on Alzheimer's patients, which could give drugmakers a faster, cheaper path through FDA review.
2. 2 Cancer Vaccine Trial Results Spark Biotech Stock RallyEarly results showing reduced cancer recurrence have renewed Wall Street interest in personalized vaccine makers and put the FDA's review timeline in focus.
3. 3 Virginia Democrat faces cannabis trafficking chargesVirginia Sen. Louise Lucas faces criminal charges in an alleged cannabis scheme, raising questions about lawmaker oversight before the midterms.
4. 4 GOP divided over aggressive Ohio Senate attack adVice President Vance urged Republicans to back an ad targeting the estranged mother of Amy Acton, which has exposed divisions over campaign strategy.
5. 5 PHP Flaw Exposes Wall Street Cyber VulnerabilitiesA critical PHP vulnerability has taken websites offline worldwide, prompting new scrutiny of cybersecurity defenses in American finance and tech.